Expand PLSE Menu
PLSE MENU

PLSE Latest Press Releases

-- May 27, 2026 --

Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026 Business Wire 4:05 PM

-- May 12, 2026 --

ATM Equity Purchases by Pulse Biosciences' Co-Chairmen Total Approximately $13.3 Million Business Wire 7:00 AM

-- May 8, 2026 --

Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference Business Wire 7:00 AM

-- May 4, 2026 --

Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Results Business Wire 7:00 AM

-- April 25, 2026 --

Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse Cardiac Catheter System at Heart Rhythm 2026 Business Wire 1:00 PM

-- April 20, 2026 --

Pulse Biosciences' nPulse Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting Business Wire 7:00 AM

-- April 17, 2026 --

Pulse Biosciences to Host Analyst Event on April 25, 2026 Business Wire 7:00 AM

-- April 9, 2026 --

Pulse Biosciences Strengthens Executive Leadership Team Business Wire 7:00 AM

-- April 7, 2026 --

Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse Cardiac Catheter System for Atrial Fibrillation Business Wire 7:00 AM

-- April 2, 2026 --

Pulse Biosciences to Present at the 25th Annual Needham Virtual Healthcare Conference Business Wire 4:05 PM

-- March 17, 2026 --

Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data Business Wire 7:00 AM

-- March 12, 2026 --

Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse Technology Business Wire 7:00 AM

-- March 9, 2026 --

Pulse Biosciences Announces Clinical Data From nPulse Vybrance System First-In-Human Clinical Durability Study of Benign Thyroid Nodule Ablation Business Wire 7:00 AM

-- March 5, 2026 --

Pulse Biosciences to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference Business Wire 7:00 AM

-- March 4, 2026 --

Pulse Biosciences' nPulse Vybrance System to be Featured in Multiple Presentations at the North American Society for Interventional Thyroidology Meeting Business Wire 7:00 AM

-- February 20, 2026 --

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:05 PM
Pulse Biosciences to Present at the 46th Annual TD Cowen Healthcare Conference Business Wire 7:00 AM

-- February 19, 2026 --

Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2025 Financial Results Business Wire 4:05 PM

-- February 5, 2026 --

Pulse Biosciences Presents Late-Breaking Data from nPulse Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium Business Wire 7:00 PM

-- February 4, 2026 --

Pulse Biosciences Schedules Fourth Quarter & Full Year 2025 Financial Results Conference Call for February 19, 2026 Business Wire 4:05 PM

-- February 3, 2026 --

Pulse Biosciences' nPulse Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium Business Wire 7:00 AM

-- January 9, 2026 --

Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors Business Wire 7:00 AM

-- January 6, 2026 --

Pulse Biosciences Selected to Present Late-Breaking Data from the nPulse Cardiac Catheter Study at the AF Symposium Business Wire 7:00 AM
Market Data Delayed 15 Minutes